Basics Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health. IPO Date: April 1, 1993 Sector: Healthcare Industry: Biotech Market Cap: $343.91M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.48% Avg Daily Range (30 D): $0.32 | 1.86% Avg Daily Range (90 D): $0.29 | 1.76% Institutional Daily Volume Avg Daily Volume: 2.72M Avg Daily Volume (30 D): .1M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 303 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 4,736 Avg Inst. Trade: $1.26M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $1.18M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 6.75K     News Nov 11, 2025 @ 7:27 PM RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE ... Source: Recordati S.P.A. Nov 9, 2025 @ 9:15 PM New REDUCE-IT® Aspirin Analysis Presented at AH... Source: Amarin Corporation Oct 14, 2025 @ 12:00 PM Amarin and HLS Therapeutics Collaborate on Present... Source: Amarin Corporation Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc Dec 13, 2024 @ 2:00 PM Amarin Appoints Peter Fishman Chief Financial Offi... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.21 $-.02 $-.03 Diluted EPS $-.21 $-.02 $-.03 Revenue $ 226.73M $ 49.67M $ 72.74M Gross Profit $ 88.13M $ 22.21M $ 50.36M Net Income / Loss $ -86.19M $ -7.74M $ -14.14M Operating Income / Loss $ -96.37M $ -11.1M $ -15.99M Cost of Revenue $ 138.6M $ 27.46M $ 22.38M Net Cash Flow $ -34.37M $ -25.07M $ 28.35M PE Ratio     Splits Apr 11, 2025:   1:20 Jan 18, 2008:   1:10